↓ Skip to main content

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese…

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
Published in
Orphanet Journal of Rare Diseases, July 2014
DOI 10.1186/s13023-014-0111-y
Pubmed ID
Authors

Hao-Chuan Liu, Hsiang-Yu Lin, Chia-Feng Yang, Hsuan-Chieh Liao, Ting-Rong Hsu, Chiao-Wei Lo, Fu-Pang Chang, Chun-Kai Huang, Yung-Hsiu Lu, Shuan-Pei Lin, Wen-Chung Yu, Dau-Ming Niu

Abstract

In Taiwan, DNA-based newborn screening showed a surprisingly high incidence (1/875 in males and 1/399 in females) of a cardiac Fabry mutation (IVS4 + 919G > A). However, the natural course, long-term treatment outcomes and suitable biomarkers for monitoring the therapeutic outcomes of these patients are largely unknown.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 15%
Student > Master 7 15%
Other 6 13%
Student > Ph. D. Student 6 13%
Professor > Associate Professor 4 9%
Other 12 26%
Unknown 5 11%
Readers by discipline Count As %
Medicine and Dentistry 17 36%
Biochemistry, Genetics and Molecular Biology 8 17%
Agricultural and Biological Sciences 7 15%
Neuroscience 2 4%
Nursing and Health Professions 2 4%
Other 3 6%
Unknown 8 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2014.
All research outputs
#3,502,120
of 4,506,051 outputs
Outputs from Orphanet Journal of Rare Diseases
#710
of 775 outputs
Outputs of similar age
#83,313
of 109,999 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#46
of 47 outputs
Altmetric has tracked 4,506,051 research outputs across all sources so far. This one is in the 3rd percentile – i.e., 3% of other outputs scored the same or lower than it.
So far Altmetric has tracked 775 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,999 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.